HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dermatitis during radiation for vulvar carcinoma: prevention and treatment with granulocyte-macrophage colony-stimulating factor impregnated gauze.

Abstract
The aim of this study was to determine the effectiveness of granulocyte-macrophage colony-stimulating factor (GM-CSF) impregnated gauze in preventing or healing radiation-induced dermatitis. Sixty-one patients were irradiated for vulvar carcinoma. Thirty-seven applied steroid cream at irradiated areas throughout radiotherapy (Group A) and 24 patients applied additionally GM-CSF impregnated gauze (40 micrcog/cm2 of skin-irradiated area, twice per day) in addition to the steroid cream, after 20 Gy of irradiation (Group B). The score of skin reactions (P=0.008, chi2 test) and the time interval of radiotherapy interruption (P=0.037, Mann-Whitney U test) were statistically significantly reduced in Group B patients. Multivariate analysis of variance showed for this group not only a significant reduction in the Sum of Gross Dermatitis Scoring (P<0.001, adjusted for Duration of Dermatitis) but also a significant reduction of the healing time (P=0.02, adjusted for Sum of Gross Dermatitis Scoring). The pain grading was less (P=0.014, chi2 test) and pain reduction was noticed sooner after the application of GM-CSF impregnated gauze (P=0.0017, Mann-Whitney U test). Multivariate logistic regression analysis showed that the only significant effect on dermatitis score is due to Body Mass Index (P=0.034) and the application of GM-CSF (P=0.008). GM-CSF impregnated gauze can be effective in preventing and healing radiation-induced dermatitis and in reducing the interruption intervals of radiotherapy for vulvar carcinomas.
AuthorsJ R Kouvaris, V E Kouloulias, G A Plataniotis, E J Balafouta, L J Vlahos
JournalWound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society (Wound Repair Regen) 2001 May-Jun Vol. 9 Issue 3 Pg. 187-93 ISSN: 1067-1927 [Print] United States
PMID11472614 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Betamethasone
Topics
  • Acute Disease
  • Administration, Cutaneous
  • Adult
  • Aged
  • Aged, 80 and over
  • Bandages
  • Betamethasone (administration & dosage)
  • Carcinoma, Squamous Cell (radiotherapy)
  • Clinical Nursing Research
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor (administration & dosage)
  • Humans
  • Logistic Models
  • Middle Aged
  • Multivariate Analysis
  • Pain (diagnosis, etiology)
  • Primary Prevention (methods)
  • Radiodermatitis (classification, etiology, nursing, prevention & control)
  • Severity of Illness Index
  • Skin Care (methods, nursing)
  • Treatment Outcome
  • Vulvar Neoplasms (radiotherapy)
  • Wound Healing

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: